BIOXYNE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 AUD | 0.00% |
|
-16.67% | -54.55% |
| 05-14 | Bioxyne to Release Shares from Escrow; Shares Up 17% | MT |
| 05-14 | Bioxyne Subsidiary, CY Biopharma Enter Partnership to Advance Novel Psilocybin Therapies in Australia | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOXYNE LIMITED | Other Biotechnology & Medical Research | 0.00% | -16.67% | -54.55% | -80.00% | -68.75% | 6.79M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- BXN Stock
- Charts Bioxyne Limited
- Comparison Chart
